Delirium as a mediating factor in the survival benefits of dexmedetomidine in acute brain injury management
Abstract Acute brain injury (ABI) is a leading cause of ICU admission and mortality. Effective sedation is essential for preventing secondary brain injury, and dexmedetomidine has emerged as a potential neuroprotective agent. We conducted a retrospective analysis using the MIMIC-IV v3.1 database, in...
Saved in:
| Main Authors: | Juan Wang, Jia-qing Sun, Yue Lu, Qi-lin Yang, Peng-lai Zhao, Chun-Hua Hang, Wei Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-14180-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Dexmedetomidine on Hospital and Intensive Care Unit Stay Duration in Adult Traumatic Brain Injury Patients: A Systematic Review
by: Alaifan T, et al.
Published: (2025-07-01) -
Influence of Sedation with Dexmedetomidine on Oxidative Distress During Delirium Developed Following Severe Polytrauma
by: F. F. Bershadsky, et al.
Published: (2019-09-01) -
Dexmedetomidine for the prevention of postoperative delirium in patients undergoing cardiac surgery: a systematic review and meta-analysis with trial sequential analysis
by: Yiyang Zhong, et al.
Published: (2025-08-01) -
Effects of Intranasal dexmedetomidine and esketamine for premedication on postoperative pain after tonsillectomy and adenoidectomy in children: a randomized clinical trial
by: Jun-wei Qi, et al.
Published: (2025-07-01) -
POSTOPERATIVE DELIRIUM: WHAT NEW DOES NOVEL GUIDELINES BY ESA-2017 OFFER?
by: V. V. Likhvantsev, et al.
Published: (2018-01-01)